- 收听数
- 0
- 性别
- 保密
- 听众数
- 2
- 最后登录
- 2015-9-30
- QQ
 - UID
- 8195
- 阅读权限
- 10
- 帖子
- 299
- 精华
- 0
- 在线时间
- 108 小时
- 注册时间
- 2014-2-19
- 科研币
- 2
- 速递币
- 49
- 娱乐币
- 7359
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
5速递币
| 题名 | Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis | | 链接 | http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62002-X/abstract |
|
|
发表于 2015-7-6 15:17:35
淘帖
收藏
顶
踩
